{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:42:54Z","timestamp":1790898174775,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/pas.0b013e31824c0d92","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T13:06:31Z","timestamp":1334235991000},"page":"779-782","source":"Crossref","is-referenced-by-count":29,"title":["Malignant Transformation of Mastocytoma Developed on Skin Mastocytosis Into Cutaneous Mast Cell Sarcoma"],"prefix":"10.1097","volume":"36","author":[{"given":"Isabelle","family":"Auquit-Auckbur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e2lin","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Deneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Guillemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Cordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2353\/jmoldx.2006.060022","article-title":"Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on molecular pathology.","volume":"8","author":"Akin","year":"2006","journal-title":"J Mol Diagn"},{"issue":"suppl 2","key":"R2-18-20210131","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/modpathol.2008.9","article-title":"Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas.","volume":"21","author":"Antonescu","year":"2008","journal-title":"Mod Pathol"},{"key":"R3-18-20210131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1524-4725.1993.tb00377.x","article-title":"Solitary mastocytoma in adults. Treatment by excision.","volume":"19","author":"Ashinoff","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"R4-18-20210131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1994.tb00560.x","article-title":"Urticaria pigmentosa: a review of 67 pediatric cases.","volume":"11","author":"Azana","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"R5-18-20210131","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.2006.040857","article-title":"Mast-cell sarcoma of the tibia.","volume":"60","author":"Brcic","year":"2007","journal-title":"J Clin Pathol"},{"key":"R6-18-20210131","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00000478-200307000-00019","article-title":"Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.","volume":"27","author":"Chott","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R7-18-20210131","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejca.2003.11.025","article-title":"Use of c-KITPDGFRA mutations analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumors entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.","volume":"40","author":"Debiec-Rychter","year":"2004","journal-title":"Eur J Cancer"},{"key":"R8-18-20210131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1024\/0040-5930.63.4.273","article-title":"The diagnostic and predictive role of kit (CD117).","volume":"63","author":"Dirnhofer","year":"2006","journal-title":"Ther Umsch"},{"key":"R9-18-20210131","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1078-0432.CCR-0778-03","article-title":"Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factorKIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.","volume":"10","author":"Gonzalez","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R10-18-20210131","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/cncr.24944","article-title":"The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.","volume":"116","author":"Gronchi","year":"2010","journal-title":"Cancer"},{"key":"R11-18-20210131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00043426-200102000-00014","article-title":"Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.","volume":"23","author":"Guenther","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-18-20210131","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.39.6.596","article-title":"Mast cell sarcoma of the larynx.","volume":"39","author":"Horny","year":"1986","journal-title":"J Clin Pathol"},{"key":"R13-18-20210131","first-page":"197","article-title":"Pediatric mastocytosis.","volume":"73","author":"Kettelhut","year":"1994","journal-title":"Ann Allergy"},{"key":"R14-18-20210131","first-page":"739","article-title":"Mast cell sarcoma with tissue eosinophilia arising in the ascending colon.","volume":"12","author":"Kojima","year":"1999","journal-title":"Mod Pathol"},{"key":"R15-18-20210131","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.3324\/haematol.11996","article-title":"Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens.","volume":"92","author":"Krauth","year":"2007","journal-title":"Haematologica"},{"key":"R16-18-20210131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s002920050215","article-title":"Association of bone marrow mastocytosis with extremely immature extramedullary mast cell sarcoma.","volume":"18","author":"Sotlar","year":"1997","journal-title":"Pathologe"},{"key":"R17-18-20210131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/jid.2009.197","article-title":"Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.","volume":"130","author":"Terheyden","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R18-18-20210131","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6602592","article-title":"Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.","volume":"92","author":"Uziel","year":"2005","journal-title":"Br J Cancer"},{"key":"R19-18-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics, and current options for therapy.","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"suppl 2","key":"R20-18-20210131","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1111\/j.0960-135X.2004.01369.x","article-title":"On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.","volume":"34","author":"Valent","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"R21-18-20210131","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"R22-18-20210131","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effects of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-Kit receptors found in mast cells neoplasms.","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-201205000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:31:19Z","timestamp":1618036279000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201205000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31824c0d92","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}